ClinConnect ClinConnect Logo
Search / Trial NCT02551770

Emdogain Minimally Invasive Surgical Technique

Launched by INSTITUT STRAUMANN AG · Sep 14, 2015

Trial Information

Current as of June 10, 2025

Completed

Keywords

ClinConnect Summary

The aim of the study will be achieved through the following primary and secondary objectives. The primary objective is to evaluate the regenerative potential of Straumann Emdogain by comparing the change in clinical attachment level from baseline to 12 months between the test and control arms. The regenerative potential of Straumann Emdogain will also be assessed by comparing the changes in gingival margins, changes in average probing pocket depth, changes in full mouth plaque score, changes in bleeding on probing, and changes in root dentin hypersensitivity from baseline to 12 months betwe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects must have voluntarily signed the informed consent form before any study related procedures
  • Subjects must be males or females who are 18-85 years of age
  • Subjects must have moderate to severe chronic, generalized periodontitis with pockets of 5 mm - 8mm probing depth in at least 2 pockets per contralateral quadrants in one arch (study teeth)
  • Subjects must be committed to the study and the required follow-up visits
  • Subjects must be in good general health as assessed by the Investigator
  • Exclusion Criteria:
  • Subjects taking or intending to take any medications during the duration of the study that will potentially affect healing and inflammation
  • Subjects who are currently heavy smokers (defined \>10 cigarettes per day or \>1 cigar per day) or who use chewing tobacco
  • Subjects being treated with systemic antibiotics or subjects that were treated with systemic antibiotics within 3 months prior to treatment in this study
  • Subjects with uncontrolled diabetes
  • Subjects that are immunocompromised or immunosuppressed
  • Subjects that cannot provide informed consent
  • Subjects with drug or alcohol abuse
  • Subjects that have undergone periodontal root planing or periodontal surgery in the last 6 months
  • Subjects that are pregnant
  • Subjects with necrotizing periodontitis or periodontitis related to systemic disease
  • Teeth with pockets with probing depth ≥ 9 mm will not classify as study teeth
  • Teeth with pockets or defects with furcation involvement will not classify as study teeth
  • Teeth with mobility degree \> 1 without splint will not classify as study teeth
  • Subjects with test and control sites in the two quadrants on adjacent teeth
  • Patients with compromised health conditions such as diabetes, systemic diseases, high dose steroid therapy, bone metabolic diseases, radiation or immune-oppressive therapy, and infections or vascular impairment at the surgical site
  • Subjects with conditions or circumstances, in the opinion of the Investigator , which would prevent completion of study participation or interfere with analysis of study results

About Institut Straumann Ag

Institut Straumann AG is a leading global provider of dental implant solutions and restorative dentistry, committed to advancing oral health through innovative technologies and comprehensive solutions. With a strong emphasis on research and development, the company is dedicated to enhancing patient outcomes by delivering high-quality products and services that meet the evolving needs of dental professionals. As a clinical trial sponsor, Institut Straumann AG focuses on rigorous scientific evaluation and collaboration with key stakeholders to ensure the safety and efficacy of its offerings, ultimately striving to set new standards in the field of dental care.

Locations

Mainz, , Germany

Cullman, Alabama, United States

Aurora, Colorado, United States

Montreal, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Pamela K McClain, DDS

Principal Investigator

Periodontics and Implant Dentistry

Veronique Benhamou, DDS

Principal Investigator

Clinique Paro Excellence

Jennifer H Doobrow, DMD

Principal Investigator

Periodontal & Implant Associates

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials